PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
17.01
+0.32 (1.89%)
At close: May 6, 2026, 4:00 PM EDT
17.25
+0.24 (1.44%)
After-hours: May 6, 2026, 4:00 PM EDT
PureTech Health Employees
PureTech Health had 56 employees as of December 31, 2024. The number of employees decreased by 34 or -37.78% compared to the previous year.
Employees
56
Change (1Y)
-34
Growth (1Y)
-37.78%
Revenue / Employee
$83,196
Profits / Employee
-$1,959,625
Market Cap
425.06M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 56 | -34 | -37.78% |
| Dec 31, 2023 | 90 | -21 | -18.92% |
| Dec 31, 2022 | 111 | 16 | 16.84% |
| Dec 31, 2021 | 95 | -155 | -62.00% |
| Dec 31, 2020 | 250 | -50 | -16.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Vanda Pharmaceuticals | 533 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
PRTC News
- 6 days ago - PureTech Health PLC (PTCHF) Full Year 2025 Earnings Call Highlights: Strategic Innovations and ... - GuruFocus
- 6 days ago - Full Year 2025 PureTech Health PLC Earnings Call Transcript - GuruFocus
- 7 days ago - PureTech Health Earnings Call Transcript: H2 2025 - Transcripts
- 7 days ago - PureTech Health (PRTC) to Delist from Nasdaq, Remaining Listed on London Stock Exchange - GuruFocus
- 7 days ago - PureTech Announces Annual Results for Year Ended December 31, 2025 - Business Wire
- 7 days ago - PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange - Business Wire
- 9 days ago - PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors - Business Wire
- 14 days ago - Positive Phase 1b Results for PureTech Health (PRTC) - GuruFocus